Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

头孢氨苄胶囊 - NMPA Drug Approval Details

Approvals/NMPA/Cefalexin Capsules

Approved

化学药品

Cefalexin Capsules

博乐欣仁制药厂🇨🇳 National Medical Products Administration

Approval Date: Dec 18, 2002
Approval ID: 7zz2cKkfJB3
Company: 博乐欣仁制药厂
Type: 化学药品

Approval Details

Approval Id: 7zz2cKkfJB3
Approval Number: 国药准字H65020188
Generic Name: 头孢氨苄胶囊
Generic Name En: Cefalexin Capsules
Drug Type: 化学药品
Strength: 0.125g(按C16H17N3O4S计)
Reg Date: 2002-12-18
Company Name: 博乐欣仁制药厂
Production Company Address: 博乐市团结路90号
Company Detail Path: /organization/bo-le-xin-ren-zhi-yao-han

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 18, 2002

Approval ID

7zz2cKkfJB3

Type

化学药品

Back to NMPA Approvals